|
Medsn
Joins Forces with Indegene to Create a Global Medical Education,
Marketing, and Sales Training Services Company
Los Angeles, California,
USA and Bangalore, India, September 13, 2005 -
Medsn, Inc., a leading medical education, sales training, and marketing
services provider based in the United States, today announced that it has
merged with the Indegene group of companies, the preeminent medical
education, training, and marketing services provider in India and Asia.
The combined companies will continue to operate in the United States as
Medsn, Inc.
The newly merged firms bring to the
fore proven development and delivery capabilities; a global talent pool
exceeding 200, including more than 60 physicians, pharmacists, and allied
health care professionals; and geographic coverage in the biggest and
fastest-growing markets, with offices in Los Angeles, Jersey City,
Chicago, Philadelphia, Bangalore, New Delhi, Mumbai, and Singapore. Medsn
will now leverage the capabilities of its global workforce to deliver
unprecedented quality in a timely and cost-effective manner to its
pharmaceutical, biotechnology, and medical device customers in the United
States. The merger will also significantly enhance Medsn’s ability to
support the launches of its customers’ products worldwide.
“As our customers continue to expand
their global presence in India and Asia,” says Dennis Bonilla, President
and CEO of Medsn, “our newly forged partnership with Indegene will enable
our firm to better address those customers’ strategic needs. While some
companies have initiated off-shoring partnerships, this is the first and
only example of two companies merging that have similar go-to-market
strategies, are both market leaders in their geographies, and are both
focused exclusively on one vertical, healthcare. Medsn and Indegene have
combined their expertise for the past two years and have refined a
delivery model that will significantly improve value to our clients. We
are now in a position to drive global innovation, development, and
delivery on a 24/7 basis to support the key customer needs of quality,
cost, and speed to market. The combined teams of Indegene and Medsn, with
their strong customer relationships in their respective geographies, will
provide a solid foundation for growing a world-class company.”
“We are pioneering a unique model for
providing medical education and marketing services that will leverage
delivery capabilities and physician relationships from multiple
geographies,” adds Dr. Rajesh Nair, President and CEO of Indegene. “With
a footprint that currently spans the United States, Southeast Asia, and
India, the Indegene/Medsn combination is poised to fundamentally change
the dynamics of the industry.”
“We see this transaction as a key
step toward establishing a world-class pharmaceutical and medical device
services firm,” concludes Sriram Nadathur, Director of Nadathur Fareast,
a leading private equity firm and investor in Indegene Group. “The
Medsn-Indegene merger represents an important step in our plan to create
a consortium of global companies ranging from drug discovery to
pharmaceutical marketing that are dominant in their space. We believe
that this approach will allow us to generate significant value.”
About Medsn
Medsn is a premier medical education
and marketing company that designs and implements customized interactive
educational programs for the pharmaceutical, medical device,
biotechnology, and health care industries. Medsn employs a
multidisciplinary staff of physicians, marketing experts, industry
executives, medical illustrators, and technology specialists — all with
unique expertise in effectively merging interactive multimedia
technologies with traditional educational methods — to develop
high-impact programs that influence the behavior of physicians and
patients as well as pharmaceutical and medical device sales
representatives. The company is supported by key academic advisers at
leading institutions as well as by experts in the fields of sales and
marketing, communications, and learning.
For more information, visit www.medsn.com
About Indegene Group
Indegene is a global provider of
knowledge-intensive services that span a full spectrum of integrated
scientific promotions, medical education, and business analytical
solutions for pharmaceutical, medical device, and health care
organizations. Indegene has offices throughout India as well as
subsidiaries in Singapore and the United States. The firm boasts a highly
specialized team of physicians and medical professionals, content
developers, analysts, brand managers, and medical communication experts.
Indegene’s pioneering global delivery model for pharmaceutical services
leverages its multi-geography, multimarket advantage to deliver medical
content and communication services that provide significantly higher
return on investment and shorter delivery time for clients.
For more information, visit www.indegene.com
About Nadathur Group
Nadathur is a Bangalore, India–based
private equity firm established by N. S. Raghavan, Founder and Former
Joint Managing Director of Infosys (NASDAQ – INFY). Nadathur is focused
on the life sciences, aerospace/engineering services, and IT domains. The
firm supports a portfolio of more than 16 companies that are engaged in
leading-edge technologies, knowledge-intensive domains, and IP creation.
Through funding acquisitions and globalization initiatives, the firm is
building market-dominant consortia of companies. Nadathur Fareast is the
Singapore-based investment arm that facilitates expansion (both organic
and inorganic) of portfolio companies.
For more information, visit www.nadathur.com
Contact
Dr. Rajesh Nair
Indegene, Inc
703.946.1730
rajesh@indegene.com
|
